质子泵抑制剂与抗血小板药精.ppt
《质子泵抑制剂与抗血小板药精.ppt》由会员分享,可在线阅读,更多相关《质子泵抑制剂与抗血小板药精.ppt(19页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、质子子泵抑制抑制剂与抗血小板与抗血小板药第1页,本讲稿共19页Omeprazole 奥美拉唑奥美拉唑 1988Lansoprazole 兰索拉唑兰索拉唑 1991Pantoprazole 泮托拉唑泮托拉唑 1994Ilaprazole 艾普拉唑艾普拉唑1998Rabeprazole 雷贝拉唑雷贝拉唑 1999Esomeprazole 埃索美拉唑埃索美拉唑 2000Dexlansoprazole 右旋兰索拉唑右旋兰索拉唑 2009Proton Pump Inhibitors on Marketing解放军总医院消化病中心解放军总医院消化病中心 Great success to control A
2、cid related diseases in the past 2 decades -NV-UGIB,Peptic Ulcer,GERD,etc.第2页,本讲稿共19页The potential benefits of antiplatelet therapy for atherosclerotic cardiovascular(CV)disease have been amply demonstrated over the past 20 years,especially thienopyridine drugs in preventing stent thrombosis.Antipla
3、telet agents increase the risk of bleeding associated with mucosal breaks in the upper and lower gastrointestinal(GI)tract.Rational use of thienopyridines is based on weighing their risks against their benefits.Balance between Benefits and Risks解放军总医院消化病中心解放军总医院消化病中心第3页,本讲稿共19页791 residents studied6
4、0 were prescribed clopidogrel248 were on aspirin 326 were prescribed a PPI.Among residents who were prescribed PPIs155 were prescribed omeprazole;72 pantoprazole51 rabeprazole;44 esomeprazole;15 lansoprazole.39 residents took a combination of clopidogrel and a PPI(any PPI)for a mean 203 days.9 resid
5、ents took the combination of clopidogrel,aspirin and a PPI(any PPI)for a mean of 173 days.The Prevalence of Co-administrationClopidogrel and Proton Pump Inhibitors Shrestha K.et al.Qual Prim Care.2011;19(1):35-42解放军总医院消化病中心解放军总医院消化病中心第4页,本讲稿共19页Oral antiplatelet therapy may increase bleeding complic
6、ations,the largest proportion due to GI hemorrhage.Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding.2008 Expert Consensus ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the GI Risks of Antiplatelet Therapy and NSAID Use解放军总医院消化病中心解放军总医院消化病中心第5页,本讲稿共
7、19页2008 Expert Consensus ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the GI Risks of Antiplatelet Therapy and NSAID Use解放军总医院消化病中心解放军总医院消化病中心第6页,本讲稿共19页Many investigations of potential adverse interaction has been conducted recentlyEvidence of a possible adverse drug interaction between
8、PPIs and thienopyridines has emergedIt has been difficult for physicians including cardiologists,gastroenterologists and all practionersHow to treat our patients with both kinds of drugs解放军总医院消化病中心解放军总医院消化病中心Potential adverse interaction 2010 Expert Consensus Document on the Concomitant Use of PPIs
9、and Thienopyridines JACC Vol.56,No.24,2010第7页,本讲稿共19页解放军总医院消化病中心解放军总医院消化病中心Metabolism of clopidogrel and PPI第8页,本讲稿共19页Metabolism of PPIsAll PPIs are hepatically metabolized to an extent via the cytochrome P450 mixed oxidase system.The isoenzymes CYP3A4,particularly CYP2C19 are the major isoforms th
10、at cause PPI biotransformation.The relative contribution of CYP2C19 pathway differs among drugs and has been reported to be omeprazole=esomeprazole pantoprazole lansoprazole rabeprazole in general metabolism In contrast to the situation with clopidogrel,reduced CYP2C19 function results in less inact
11、ivation of PPI and an increase in pharmacodynamic effect(greater acid inhibition).解放军总医院消化病中心解放军总医院消化病中心Metabolism of clopidogrel and PPIFock KM et al.Clin Pharmacokinet 2008;47:1-6第9页,本讲稿共19页A reduction in active metabolite levels of about 45%was found in people who received clopidogrel with omepra
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 质子 抑制剂 血小板
限制150内